Gene · 4824
Papers3,429
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 3,429
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrated Genomic Analysis of Primary Prostate Tumor Foci and Corresponding Lymph Node Metastases Identifies Mutations and Pathways Associated with Metastasis. | Cancers (Basel) | 2023 | 38067373 | PubTator, text mining | PubMed |
| The PENGUIN approach to reconstruct protein interactions at enhancer-promoter regions and its application to prostate cancer. | Nat Commun | 2023 | 38057321 | PubTator, text mining | PubMed |
| Rational optimization of a transcription factor activation domain inhibitor. | Nat Struct Mol Biol | 2023 | 38049566 | PubTator, text mining | PubMed |
| CRISPR-Cas12a-integrated transgenes in genomic safe harbors retain high expression in human hematopoietic iPSC-derived lineages and primary cells. | iScience | 2023 | 38034357 | PubTator, text mining | PubMed |
| Recurrent Left Renal Fossa Clear Cell Renal Cell Carcinoma With Pancreatic Tail Invasion Presenting as Intestinal Obstruction. | Cureus | 2023 | 38034254 | PubTator, text mining | PubMed |
| Metastatic prostatic adenocarcinoma presenting as generalized lymphadenopathy unmasked by a COVID booster vaccine. | Clin Case Rep | 2023 | 38033690 | PubTator, text mining | PubMed |
| Dramatic response and acquired resistance to savolitinib in advanced intrahepatic cholangiocarcinoma with MET amplification: a case report and literature review. | Front Oncol | 2023 | 38023194 | PubTator, text mining | PubMed |
| Identification of a 24-gene panel and a novel marker of PODXL2 essential for the pathological diagnosis of early prostate cancer. | Comput Struct Biotechnol J | 2023 | 38022698 | PubTator, text mining | PubMed |
| The ELAVL3/MYCN positive feedback loop provides a therapeutic target for neuroendocrine prostate cancer. | Nat Commun | 2023 | 38016952 | PubTator, text mining | PubMed |
| Quercetin as a Therapeutic Product: Evaluation of Its Pharmacological Action and Clinical Applications-A Review. | Pharmaceuticals (Basel) | 2023 | 38004496 | PubTator, text mining | PubMed |
| New insights into the regulation of METTL3 and its role in tumors. | Cell Commun Signal | 2023 | 37996892 | PubTator, text mining | PubMed |
| Neurokinin-2 receptor negatively modulates substance P responses by forming complex with Neurokinin-1 receptor. | Cell Biosci | 2023 | 37968728 | PubTator, text mining | PubMed |
| Evolution of the Spider Homeobox Gene Repertoire by Tandem and Whole Genome Duplication. | Mol Biol Evol | 2023 | 37935059 | PubTator, text mining | PubMed |
| Two cases of prostate cancer with disseminated carcinomatosis of the bone marrow treated with novel hormonal agents. | IJU Case Rep | 2023 | 37928277 | PubTator, text mining | PubMed |
| Prioritizing cardiovascular disease-associated variants altering NKX2-5 and TBX5 binding through an integrative computational approach. | J Biol Chem | 2023 | 37926287 | PubTator, text mining | PubMed |
| Cutaneous Metastases in Progressive Prostate Adenocarcinoma: A Case Report and Literature Review. | Cureus | 2023 | 37905289 | PubTator, text mining | PubMed |
| Association of HLA-A*11:01, -A*24:02, and -B*18:01 with Prostate Cancer Risk: A Case-Control Study. | Int J Mol Sci | 2023 | 37895076 | PubTator, text mining | PubMed |
| Analysis of genetic biomarkers, polymorphisms in ADME-related genes and their impact on pharmacotherapy for prostate cancer. | Cancer Cell Int | 2023 | 37858151 | PubTator, text mining | PubMed |
| Single-cell profiling reveals immune disturbances landscape and HLA-F-mediated immune tolerance at the maternal-fetal interface in preeclampsia. | Front Immunol | 2023 | 37854606 | PubTator, text mining | PubMed |
| Chromatin compartmentalization regulates the response to DNA damage. | Nature | 2023 | 37853125 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4824/papers?page=12